$MLKN
MILLERKNOLL, INC. Stock $mlkn

$mlkn Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000006638224000004 Filed on January 10, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2022 Q4
Revenue	$872.3M	$949.5M	$1.067B
YoY Change	-11.41%	-11.0%	3.96%
Cost Of Revenue	$535.3M	$577.5M	$699.3M
YoY Change	-17.53%	-17.42%	3.49%
Gross Profit	$337.0M	$372.0M	$367.6M
YoY Change	0.42%	1.2%	4.14%
Gross Profit Margin	38.63%	39.18%	34.45%
Selling, General & Admin	$271.1M	$287.6M	$290.8M
YoY Change	2.42%	-1.1%	-8.73%
% of Gross Profit	80.45%	77.31%	79.11%
Research & Development	$21.40M	$22.20M	$23.40M
YoY Change	-9.32%	-5.13%	-17.02%
% of Gross Profit	6.35%	5.97%	6.37%
Depreciation & Amortization	$37.00M	$37.40M	$38.10M
YoY Change	-3.14%	-1.84%	-24.1%
% of Gross Profit	10.98%	10.05%	10.36%
Operating Expenses	$292.5M	$311.6M	$314.2M
YoY Change	-6.97%	-0.83%	-9.4%
Operating Profit	$44.50M	$60.40M	$53.40M
YoY Change	109.91%	13.11%	1305.26%
Interest Expense	-$17.10M	$19.80M	-$17.60M
YoY Change	-189.53%	-212.5%	-291.3%
% of Operating Profit	-38.43%	32.78%	-32.96%
Other Income/Expense, Net	$1.800M	$2.400M	$500.0K
YoY Change	-109.18%	380.0%	-28.57%
Pretax Income	$27.50M	$44.30M	$21.60M
YoY Change	1618.75%	105.09%	-590.91%
Income Tax	$4.400M	$9.500M	$4.300M
% Of Pretax Income	16.0%	21.44%	19.91%
Net Earnings	$22.20M	$33.50M	$16.00M
YoY Change	5450.0%	109.38%	-1041.18%
Net Earnings / Revenue	2.54%	3.53%	1.5%
Basic Earnings Per Share	$0.31	$0.45	$0.21
Diluted Earnings Per Share	$0.30	$0.45	$210.9K
COMMON SHARES
Basic Shares Outstanding	72.82M shares	73.48M shares	75.56M shares
Diluted Shares Outstanding	74.15M shares	74.24M shares	75.88M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$223.6M	$225.8M	$197.5M
YoY Change	2.99%	14.33%	-15.85%
Cash & Equivalents	$223.6M	$225.8M	$197.5M
Short-Term Investments
Other Short-Term Assets	$103.7M	$8.900M	$127.3M
YoY Change	-20.05%	-93.01%	1800.0%
Inventory	$437.4M	$448.2M	$587.1M
Prepaid Expenses	$89.90M	$82.00M
Receivables	$318.7M	$319.9M	$398.0M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.083B	$1.114B	$1.310B
YoY Change	-15.1%	-14.93%	7.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$883.0M	$517.9M	$962.0M
YoY Change	-5.84%	-46.16%	62.83%
Goodwill	$1.226B	$1.228B
YoY Change	0.67%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$132.9M	$133.5M	$118.9M
YoY Change	-93.87%	12.28%	61.99%
Total Long-Term Assets	$3.012B	$3.041B	$3.138B
YoY Change	-3.06%	-3.09%	-3.48%
TOTAL ASSETS
Total Short-Term Assets	$1.083B	$1.114B	$1.310B
Total Long-Term Assets	$3.012B	$3.041B	$3.138B
Total Assets	$4.095B	$4.156B	$4.448B
YoY Change	-6.56%	-6.58%	-0.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$242.0M	$250.7M	$281.6M
YoY Change	-14.4%	-10.97%	-15.59%
Accrued Expenses	$312.1M	$331.4M	$360.1M
YoY Change	-25.62%	-7.97%	-4.13%
Deferred Revenue	$85.50M	$92.90M
YoY Change	-12.22%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%		-100.0%
Long-Term Debt Due	$40.90M	$38.80M	$28.80M
YoY Change	32.36%	34.72%	-1.71%
Total Short-Term Liabilities	$680.5M	$713.8M	$773.2M
YoY Change	-7.19%	-7.68%	-9.81%
LONG-TERM LIABILITIES
Long-Term Debt	$1.290B	$1.278B	$1.435B
YoY Change	-8.81%	-10.91%	7.02%
Other Long-Term Liabilities	$626.1M	$264.9M	$699.2M
YoY Change	-9.78%	-62.11%	96.07%
Total Long-Term Liabilities	$1.917B	$264.9M	$2.134B
YoY Change	-9.13%	-87.59%	25.73%
TOTAL LIABILITIES
Total Short-Term Liabilities	$680.5M	$713.8M	$773.2M
Total Long-Term Liabilities	$1.917B	$264.9M	$2.134B
Total Liabilities	$2.704B	$2.625B	$3.014B
YoY Change	-8.3%	-12.89%	1.81%
SHAREHOLDERS EQUITY
Retained Earnings	$707.1M	$698.6M
YoY Change	1.99%
Common Stock	$14.30M	$14.60M
YoY Change	-5.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.391B	$1.421B	$1.434B
YoY Change
Total Liabilities & Shareholders Equity	$4.095B	$4.156B	$4.448B
YoY Change	-6.56%	-6.58%	-0.4%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	$22.20M	$33.50M	$16.00M
YoY Change	5450.0%	109.38%	-1041.18%
Depreciation, Depletion And Amortization	$37.00M	$37.40M	$38.10M
YoY Change	-3.14%	-1.84%	-24.1%
Cash From Operating Activities	$60.50M	$82.50M	$59.50M
YoY Change	-20.08%	38.66%	-1108.47%
INVESTING ACTIVITIES
Capital Expenditures	$16.60M	$20.00M	-$23.00M
YoY Change	-18.23%	-186.96%	-16.97%
Acquisitions
YoY Change
Other Investing Activities	-$3.100M	$5.000M	$1.200M
YoY Change	-94.96%	316.67%	-185.71%
Cash From Investing Activities	-$19.70M	-$15.00M	-$21.80M
YoY Change	-7.08%	-31.19%	-25.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-42.30M	-59.70M	-65.40M
YoY Change	25.52%	-8.72%	-292.92%
NET CHANGE
Cash From Operating Activities	60.50M	82.50M	59.50M
Cash From Investing Activities	-19.70M	-15.00M	-21.80M
Cash From Financing Activities	-42.30M	-59.70M	-65.40M
Net Change In Cash	-1.500M	7.800M	-27.70M
YoY Change	-107.21%	-128.16%	2418.18%
FREE CASH FLOW
Cash From Operating Activities	$60.50M	$82.50M	$59.50M
Capital Expenditures	$16.60M	$20.00M	-$23.00M
Free Cash Flow	$43.90M	$62.50M	$82.50M
YoY Change	-20.76%	-24.24%	278.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Restructuring Charges RestructuringCharges	1800000	usd
CY2022Q4	us-gaap	Restructuring Charges RestructuringCharges	14700000	usd
	us-gaap	Restructuring Charges RestructuringCharges	7000000.0	usd
	us-gaap	Restructuring Charges RestructuringCharges	15200000	usd
CY2023Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22200000	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23400000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44300000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	47300000	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	311600000	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	328900000	usd
	us-gaap	Operating Expenses OperatingExpenses	629400000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	60400000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	38700000	usd
CY2023Q4	us-gaap	Interest Expense InterestExpense	19800000	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	18300000	usd
	us-gaap	Interest Expense InterestExpense	39000000.0	usd
	us-gaap	Interest Expense InterestExpense	35000000.0	usd
	mlkn	Interest And Other Investment Income InterestAndOtherInvestmentIncome	1100000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	200000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-300000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	21600000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	65400000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	55300000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9500000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4300000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14600000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10600000	usd
CY2023Q4	mlkn	Income Loss From Equity Method Investments After Tax IncomeLossFromEquityMethodInvestmentsAfterTax	-400000	usd
CY2022Q4	mlkn	Income Loss From Equity Method Investments After Tax IncomeLossFromEquityMethodInvestmentsAfterTax	200000	usd
	mlkn	Income Loss From Equity Method Investments After Tax IncomeLossFromEquityMethodInvestmentsAfterTax	-300000	usd
	mlkn	Income Loss From Equity Method Investments After Tax IncomeLossFromEquityMethodInvestmentsAfterTax	200000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	34400000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	17500000	usd
	us-gaap	Profit Loss ProfitLoss	50500000	usd
	us-gaap	Profit Loss ProfitLoss	44900000	usd
CY2023Q4	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	900000	usd
CY2022Q4	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	1500000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	300000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	3100000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	33500000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	16000000.0	usd
	us-gaap	Net Income Loss NetIncomeLoss	50200000	usd
	us-gaap	Net Income Loss NetIncomeLoss	41800000	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.45
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.67
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.55
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.45
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.67
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.55
CY2023Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	7300000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	44200000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	11200000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-28300000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-400000	usd
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	100000	usd
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-800000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-7900000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	7200000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-100000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	21500000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-600000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	51800000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	11000000.0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-6000000.0	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	33800000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	69300000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	61500000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	38900000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	900000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1400000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	300000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	3100000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	32900000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	67900000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	61200000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	35800000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	225800000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	223500000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9500000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6400000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	319900000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	334100000	usd
CY2023Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	24900000	usd
CY2023Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	29400000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	448200000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	487400000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	82000000.0	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	92700000	usd
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4600000	usd
CY2023Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8900000	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	9100000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1114300000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	1176200000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1578600000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1570700000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1060700000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1034400000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	517900000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	536300000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	382500000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	415900000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1227600000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	1221700000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	482700000	usd
CY2023Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	480700000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	205000000.0	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	185200000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	297000000.0	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	313100000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	133500000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	130900000	usd
CY2023Q4	us-gaap	Assets Assets	4155500000	usd
CY2023Q2	us-gaap	Assets Assets	4274800000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	250700000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	269500000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	38800000	usd
CY2023Q2	us-gaap	Debt Current DebtCurrent	33400000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	95800000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	61700000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	76100000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	77100000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	18800000	usd
CY2023Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	20800000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	92900000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	93800000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	140700000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	146500000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	713800000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	702800000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1278200000	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1365100000	usd
CY2023Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	7700000	usd
CY2023Q2	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	7500000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	360700000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	393700000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	264900000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	265500000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2625300000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	2734600000	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	109600000	usd
CY2023Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	107600000	usd
CY2023Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2023Q2	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.20
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.20
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	240000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	240000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	73077659	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	73077659	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75698670	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	14600000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	15100000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	791500000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	836500000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	698600000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	676100000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-84100000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-95100000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1420600000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1432600000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4155500000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4274800000	usd
	us-gaap	Profit Loss ProfitLoss	50500000	usd
	us-gaap	Profit Loss ProfitLoss	44900000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	74600000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	77700000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	11700000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10900000	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	2300000	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	2300000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-400000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-300000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-300000	usd
	us-gaap	Restructuring Charges RestructuringCharges	7000000.0	usd
	us-gaap	Restructuring Charges RestructuringCharges	15200000	usd
	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	-71000000.0	usd
	us-gaap	Increase Decrease In Operating Assets IncreaseDecreaseInOperatingAssets	34700000	usd
	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-1700000	usd
	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-111900000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-2100000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-9400000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	213400000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5300000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	7100000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	4500000	usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	3500000	usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39900000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	40300000	usd
	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	0	usd
	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	13500000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-2200000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	700000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-41300000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-32000000.0	usd
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	13100000	usd
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	13100000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	386100000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	559300000	usd
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	457800000	usd
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	492300000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	28100000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	28400000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1900000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2500000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	60000000.0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	14300000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	200000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-2100000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-170800000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11600000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1000000.0	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-7100000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2300000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-32800000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	223500000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	230300000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	225800000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	197500000	usd
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75698670	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1432600000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	16700000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	11600000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6400000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	200000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	900000	usd
CY2023Q3	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	32000000.0	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.1875
CY2023Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	14100000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1422300000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	33500000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-600000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5300000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	400000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1300000	usd
CY2023Q4	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	28000000.0	usd
CY2023Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.1875
CY2023Q4	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	13700000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	100000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1420600000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5400000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000000.0	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	100000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	800000	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	14300000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.1875
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	14300000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1000000.0	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1374800000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	16000000.0	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	51800000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5500000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	100000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	700000	usd
CY2022Q4	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	100000	usd
CY2022Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.1875
CY2022Q4	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	14300000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-200000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1434300000	usd
	us-gaap	Fiscal Period FiscalPeriod	The Company's fiscal year is the 52 or 53 week period ending on the Saturday closest to May 31. The fiscal year ending June 1, 2024 contains 52 weeks, while fiscal year ended June 3, 2023 ("fiscal 2023") contained 53 weeks. The first quarter of fiscal 2024 contained 13 weeks and the first quarter of fiscal 2023 contained 14 weeks.
CY2023Q4	mlkn	Income Loss From Equity Method Investments After Tax IncomeLossFromEquityMethodInvestmentsAfterTax	-400000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	949500000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1066900000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1867200000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2145700000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	949500000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1066900000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1867200000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2145700000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	24400000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	71900000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	5900000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	125500000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1227600000	usd
CY2023Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	480700000	usd
	us-gaap	Indefinite Lived Intangible Assets Foreign Currency Translation Gain Loss IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	2000000.0	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	482700000	usd
CY2023Q4	us-gaap	Inventory Finished Goods And Work In Process Net Of Reserves InventoryFinishedGoodsAndWorkInProcessNetOfReserves	330300000	usd
CY2023Q2	us-gaap	Inventory Finished Goods And Work In Process Net Of Reserves InventoryFinishedGoodsAndWorkInProcessNetOfReserves	357200000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	117900000	usd
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	130200000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	448200000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	487400000	usd
CY2023Q2	us-gaap	Goodwill Gross GoodwillGross	1347200000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.060
CY2022Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.060
	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.060
	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.060
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	33500000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	16000000.0	usd
	us-gaap	Net Income Loss NetIncomeLoss	50200000	usd
	us-gaap	Net Income Loss NetIncomeLoss	41800000	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73655409	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75370514	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74573958	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75458089	shares
CY2023Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	584884	shares
CY2022Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	507564	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	503754	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	584551	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74240293	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75878078	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75077712	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76042640	shares
CY2023Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4277783	shares
CY2022Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2654297	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4079832	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1171951	shares
CY2023Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5300000	usd
CY2022Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5500000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11700000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10900000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1200000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1300000	usd
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2800000	usd
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2600000	usd
CY2023Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.214
CY2022Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.198
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.224
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.192
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	900000	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	700000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1600000	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1600000	usd
	us-gaap	Derivatives Methods Of Accounting Hedging Derivatives DerivativesMethodsOfAccountingHedgingDerivatives	<div style="margin-bottom:6pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:130%">Derivative Instruments and Hedging Activities</span></div><div style="margin-bottom:6pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:130%">Foreign Currency Forward Contracts</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">The Company transacts business in various foreign currencies and has established a program that primarily utilizes foreign currency forward contracts to reduce the risks associated with the effects of certain foreign currency exposures. Under this program, the Company's strategy is to have increases or decreases in our foreign currency exposures offset by gains or losses on the foreign currency forward contracts to mitigate the risks and volatility associated with foreign currency transaction gains or losses. These foreign currency exposures typically arise from net liability or asset exposures in non-functional currencies on the balance sheets of our foreign subsidiaries. These foreign currency forward contracts generally settle within 30 days and are not used for trading purposes. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">These forward contracts are not designated as hedging instruments. Accordingly, we record the fair value of these contracts as of the end of the reporting period in the Consolidated Balance Sheets with changes in fair value recorded within the Consolidated Statements of Comprehensive Income. The balance sheet classification for the fair values of these forward contracts is to Other current assets for unrealized gains and to Other accrued liabilities for unrealized losses. The Consolidated Statements of Comprehensive Income classification for the fair values of these forward contracts is to Other (income) expense, net, for both realized and unrealized gains and losses. </span></div><div style="margin-bottom:6pt"><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:130%">Interest Rate Swaps</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">The Company enters into interest rate swap agreements to manage its exposure to interest rate changes and its overall cost of borrowing. The Company's interest rate swap agreements exchange variable rate interest payments for fixed rate payments over the life of the agreement without the exchange of the underlying notional amounts. The notional amount of the interest rate swap agreements is used to measure interest to be paid or received. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">The interest rate swaps were designated as cash flow hedges at inception and the facts and circumstances of the hedged relationships remain consistent with the initial quantitative effectiveness assessment in that the hedged instruments remain an effective accounting hedge as of December 2, 2023. Since a designated derivative meets hedge accounting criteria, the fair value of the hedge is recorded in the Consolidated Statements of Stockholders’ Equity as a component of Accumulated other comprehensive loss, net of tax. The ineffective portion of the change in fair value of the derivatives is immediately recognized in earnings. The interest rate swap agreements are assessed for hedge effectiveness on a quarterly basis.</span></div>
CY2023Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-7900000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	7200000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-100000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	21500000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	7700000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	2400000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	15100000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	2000000.0	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	0	usd
CY2022Q4	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	0	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	0	usd
CY2023Q4	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	0	usd
	mlkn	Derivative Instruments Gain Loss Reclassification From Accumulated Other Comprehensive Income To Income Estimated Gross Amount To Be Transferred DerivativeInstrumentsGainLossReclassificationFromAccumulatedOtherComprehensiveIncomeToIncomeEstimatedGrossAmountToBeTransferred	27100000	usd
	us-gaap	Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred	20300000	usd
CY2023Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	73200000	usd
CY2022Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	72300000	usd
CY2023Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	73900000	usd
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	73200000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	4900000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	7400000	usd
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	10100000	usd
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	11700000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	6800000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	5600000	usd
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	12700000	usd
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	10800000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	71300000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	74100000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	71300000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	74100000	usd
CY2023Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	2300000	usd
CY2023Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	2100000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	1500000	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	usd
CY2023Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	1331300000	usd
CY2023Q2	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	1414400000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	14300000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	15900000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	38800000	usd
CY2023Q2	us-gaap	Debt Current DebtCurrent	33400000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1278200000	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1365100000	usd
CY2023Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	2300000	usd
CY2023Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	2100000	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-4000000.0	usd
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	-15000000.0	usd
	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	0	usd
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-15000000.0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	11000000.0	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-8800000	usd
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	-3100000	usd
	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	-300000	usd
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-2800000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-6000000.0	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	949500000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1066900000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1867200000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2145700000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	60400000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	38700000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	100700000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	89500000	usd
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4600000	usd
CY2023Q4	us-gaap	Restructuring Charges RestructuringCharges	1800000	usd
CY2022Q4	us-gaap	Restructuring Charges RestructuringCharges	14700000	usd
	us-gaap	Restructuring Charges RestructuringCharges	7000000.0	usd
	us-gaap	Restructuring Charges RestructuringCharges	15200000	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
mlkn-20231202_cal.xml	Edgar Link	unprocessable
mlkn-20231202_pre.xml	Edgar Link	unprocessable
mlkn-20231202_lab.xml	Edgar Link	unprocessable
mlkn-20231202_def.xml	Edgar Link	unprocessable
0000066382-24-000004-index-headers.html	Edgar Link	pending
0000066382-24-000004-index.html	Edgar Link	pending
0000066382-24-000004.txt	Edgar Link	pending
0000066382-24-000004-xbrl.zip	Edgar Link	pending
exhibit10_1x12022023.htm	Edgar Link	pending
exhibit10_1x12022023001.jpg	Edgar Link	pending
exhibit10_1x12022023002.jpg	Edgar Link	pending
exhibit10_1x12022023003.jpg	Edgar Link	pending
exhibit10_1x12022023004.jpg	Edgar Link	pending
exhibit10_1x12022023005.jpg	Edgar Link	pending
exhibit10_1x12022023006.jpg	Edgar Link	pending
exhibit10_1x12022023007.jpg	Edgar Link	pending
exhibit10_1x12022023008.jpg	Edgar Link	pending
exhibit10_1x12022023009.jpg	Edgar Link	pending
exhibit10_1x12022023010.jpg	Edgar Link	pending
exhibit10_1x12022023011.jpg	Edgar Link	pending
exhibit10_1x12022023012.jpg	Edgar Link	pending
exhibit10_1x12022023013.jpg	Edgar Link	pending
exhibit10_1x12022023014.jpg	Edgar Link	pending
exhibit10_1x12022023015.jpg	Edgar Link	pending
exhibit10_1x12022023016.jpg	Edgar Link	pending
exhibit10_1x12022023017.jpg	Edgar Link	pending
exhibit10_1x12022023018.jpg	Edgar Link	pending
exhibit10_1x12022023019.jpg	Edgar Link	pending
exhibit10_1x12022023020.jpg	Edgar Link	pending
exhibit10_1x12022023021.jpg	Edgar Link	pending
exhibit10_1x12022023022.jpg	Edgar Link	pending
exhibit10_1x12022023023.jpg	Edgar Link	pending
exhibit10_1x12022023024.jpg	Edgar Link	pending
exhibit10_1x12022023025.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
mk10q_12022023ex311.htm	Edgar Link	pending
mk10q_12022023ex312.htm	Edgar Link	pending
mk10q_12022023ex321.htm	Edgar Link	pending
mk10q_12022023ex322.htm	Edgar Link	pending
mlkn-20231202.htm	Edgar Link	pending
mlkn-20231202.xsd	Edgar Link	pending
mlkn-20231202_g1.jpg	Edgar Link	pending
mlkn-20231202_g2.jpg	Edgar Link	pending
mlkn-20231202_g3.jpg	Edgar Link	pending
mlkn-20231202_g4.jpg	Edgar Link	pending
mlkn-20231202_g5.jpg	Edgar Link	pending
mlkn-20231202_g6.jpg	Edgar Link	pending
mlkn-20231202_g7.jpg	Edgar Link	pending
mlkn-20231202_g8.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
mlkn-20231202_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLKN
MILLERKNOLL, INC. Stock $mlkn

2024 Q1 Form 10-Q Financial Statement

#000006638224000004 Filed on January 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLKN MILLERKNOLL, INC. Stock $mlkn

2024 Q1 Form 10-Q Financial Statement

#000006638224000004 Filed on January 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLKN
MILLERKNOLL, INC. Stock $mlkn